Recent studies have shown that artificial activation of the sensor protein AMPK, used to maintain the energy integrity in the body, can not only treat metabolic diseases such as type II diabetes, obesity and fatty liver, but also inhibit allergic and inflammatory reactions [13,14,15,16]. Here, PRKAA2 is linked to obesity due to melanocortin 4 receptor deficiency.